MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wreggett, K. A.
Right arrow Articles by Seeman, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wreggett, K. A.
Right arrow Articles by Seeman, P.

Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide

KA Wreggett and P Seeman

In order to determine whether D2-dopaminergic receptors in brain exist in different affinity states for agonists and whether these receptors could be completely converted from their agonist high-affinity state to their agonist low-affinity state, we examined the effect of a guanine nucleotide on the competition between [3H]spiperone and dopamine agonists for binding to homogenates of calf caudate nucleus. [3H]spiperone labeled sites having different affinities for agonists as well as antagonists. Agonists recognized three components of [3H]spiperone binding. Two of these components were related to the D2- dopaminergic receptor. These two sites appeared to represent interconvertible states, each having different affinities for agonists. This was supported by the observation of an apparent guanine nucleotide- induced "conversion" of sites with high affinity to those having low affinity for the agonist. This effect of the guanine nucleotide was incomplete, such that a significant proportion of the high-affinity sites (21%) remained in the presence of an excess of the nucleotide. These high-affinity, guanine nucleotide-insensitive sites may represent a distinct class of binding sites having high affinity for both agonists and antagonists or may be the result at equilibrium of an agonist-independent interaction of the receptor and the guanine nucleotide.

Volume 25, Issue 1, pp. 10-17, 01/01/1984
Copyright © 1984 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1984 by the American Society for Pharmacology and Experimental Therapeutics